not differ
[용어속성] Action
Psychosocial Effects and Use of Communication Technologies during Home Confinement in the First Wave of the COVID-19 Pandemic in Italy and The Netherlands
Article
[키워드] accompanied
communication
communication technology
country
COVID-19
COVID-19 pandemic
cross-sectional
decrease
depressive
Effect
European country
female
First wave
globe
highlight
home
home confinement
impacted
increase in
individual
infection rate
intensity
Italy
less
lockdown
loneliness
magnitude
Mental
Mental wellbeing
modify
Netherland
Netherlands
not differ
pandemic
participant
Psychosocial
public health
question
reduce
SARS-CoV-2
Satisfaction
significantly
significantly higher
significantly increased
Support
technology
variable
Wave
while
[DOI] 10.3390/ijerph18052619 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijerph18052619 PMC 바로가기 [Article Type] Article
Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine: results from a population-based prospective cohort in Catalonia, Spain, 2020
클로로퀸 및 하이드록시클로로퀸에 노출된 환자의 COVID-19 발병률: 2020년 스페인 카탈로니아의 인구 기반 전향적 코호트 결과
Research
[키워드] 95% confidence interval
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
administration
age
analysed
Chloroquine
chloroquine/hydroxychloroquine
Chronic exposure
classification
clinical trial
Cohort
cohort of patient
Control
controls
coronavirus
coronavirus disease
COVID-19
COVID-19 case
COVID-19 cases
COVID-19 in patient
COVID-19 incidence
database
drug
exposure to
female
Follow-up
hazard ratio
Health
health administration
hospital
hospitalisation
Hydroxychloroquine
hydroxychloroquine/chloroquine
incidence rate
Infection
lower risk
male
not differ
Patient
pre-exposure prophylaxis
primary care
prospective cohort
Protective
respiratory
Result
risk
risk of COVID-19
risk of infection
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
severe coronavirus disease
Sex
Spain
two group
two groups
[DOI] 10.2807/1560-7917.ES.2021.26.9.2001202 PMC 바로가기 [Article Type] Research
[DOI] 10.2807/1560-7917.ES.2021.26.9.2001202 PMC 바로가기 [Article Type] Research
Public Interest in Knee Pain and Knee Replacement during the SARS-CoV-2 Pandemic in Western Europe
Article
[키워드] absence
acute respiratory syndrome
addition
affected
Arthroplasty
Care
category
changed
changes in
Corona virus
coronavirus
country
declined
decrease
Europe
Frame
Frequency
Germany
Google
Google Trends
interest
investigated
knee
knee osteoarthritis
knee pain
lockdown
measure
Measures
not differ
Osteoarthritis
Pain
pandemic
Patient
patients
presenting
proportion
Public
public interest
receive
reduction
replacement
SARS-CoV-2
significantly
surgical
Symptom
the SARS-CoV-2
Total knee arthroplasty
trend
while
[DOI] 10.3390/jcm10051067 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm10051067 PMC 바로가기 [Article Type] Article
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
COVID-19로 입원한 환자의 조기 및 지연된 항-SARS-CoV-2 회복기 혈장: 무작위 2상 임상 시험
Clinical Trial
[키워드] 6 hour
6 hours
95% CI
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
addition
administration
age
aggravation
anti-SARS-CoV-2
antibody
ARMS
benefit
carried
clearance rate
clinical benefit
Clinical deterioration
clinical trial
clinically
Composite
conducted
convalescent patient
Convalescent patients
convalescent plasma
coronavirus
Corticosteroids
COVID-19
COVID-19 patients
COVID-19 progression
COVID-19 symptom
CP group
criteria
death
detect
Deterioration
Donor
early stage
early stages
Efficacy
Efficacy and safety
Elvira
Enrollment
evaluate
Evidence
evidence of
except for
Final
Follow-up
groups
high risk
hospital
Hospitalization
hospitalized patient
hospitalized patients
IMPROVE
In-hospital death
in-hospital mortality
in-hospital mortality rate
Intervention
lack
male
matter
mechanical ventilation
Mortality
mortality rate
Neutralizing antibodies
neutralizing antibody
not differ
observation
observations
Odds ratio
on mechanical ventilation
Open-label
outcome
pandemic
participant
Patient
patients hospitalized
patients with COVID-19
performed
plasma
Plasma transfusion
presenting
Primary outcome
progression
proportion
Randomized
randomized clinical trial
randomized patient
randomized trial
Real-time PCR
recruited
required
researcher
respiratory
Respiratory failure
risk factor
Risk factors
SARS-CoV-2
secondary outcome
Serious Adverse Event
Serious Adverse Events
severe acute respiratory syndrome Coronavirus
single-center
small sample size
standard treatment
Statistical power
symptomatic
symptomatic COVID-19
Symptoms
the patient
therapeutic effect
therapy
Treatment
Trial
Two patient
two patients
Viral
viral clearance rate
virus
with COVID-19
[DOI] 10.1371/journal.pmed.1003415 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1371/journal.pmed.1003415 PMC 바로가기 [Article Type] Clinical Trial
Examination of the effect of COVID-19 on sexual dysfunction in women
코로나19가 여성의 성기능 장애에 미치는 영향 조사
Article
[키워드] age
COVID-19
COVID-19 disease
diagnosed
diagnosed with COVID-19
Diagnosis
discharged
dysfunction
examination
form
Frequency
function
hospital
hospitalised
life
material
mean value
median value
not differ
Pain
Quality
Quality of life
Satisfaction
scale
sexual
sexual dysfunction
sexual intercourse
significantly
statistically
statistically significant
subgroup
subgroups
Treatment protocol
women
[DOI] 10.1111/ijcp.13923 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/ijcp.13923 PMC 바로가기 [Article Type] Article
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial
Research Paper
[키워드] Accelerator
adult outpatient
assigned
Azithromycin
cardiac
clearance
Clinical course
clinical outcomes
collected
Comprehensive
conducted
Controlled trial
coronavirus
COVID-19
deaths
double-blind
early treatment
effective therapy
EKG
Endpoint
enrolled
Enrollment
faster
finding
Folic acid
foundation
funding
HCQ
Hospitalization
Hydroxychloroquine
Infection
initiated
laboratory-confirmed SARS-CoV-2 infection
Lower respiratory tract
Mayo Clinic
median
median time
medication
Melinda Gate
morbidity
nasal swab
not differ
occurred
Outpatient
participant
Participants
Prevent
Program
progression
Randomized
randomized clinical trial
Randomized controlled trial
Randomly
receive
recruited
reduce
Remote enrollment
Rice
risk
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 PCR
SARS-CoV-2 transmission
SARS-CoV-2 viral shedding
SARV-CoV-2
Science
secondary endpoint
Seven
severe COVID-19
Smith
stratified
sudden
Support
supported
Symptom
symptom onset
symptom resolution
The United States
Therapeutics
Treatment
University of Washington
viral shedding
vital sign
with COVID-19
[DOI] 10.1016/j.eclinm.2021.100773 PMC 바로가기 [Article Type] Research Paper
[DOI] 10.1016/j.eclinm.2021.100773 PMC 바로가기 [Article Type] Research Paper
COVID-19 Impairs Immune Response to Candida albicans
COVID-19는 Candida albicans에 대한 면역 반응을 손상시킵니다
Immunology
[키워드] abrogated
Activation
acute respiratory distress
acute respiratory distress syndrome
Antigen
ARDS
Aspergillus fumigatus
Blood
Candida
Candida albican
Candida albicans
CD244
CD38
CD4
CD8
CD80
changes in
characterization
characterized
clinical parameter
Clinical parameters
coronavirus
coronavirus disease
coronavirus disease-2019
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
critically ill COVID-19 patients
cytokine
cytokine release
Cytokines
cytokines IL-6
detrimental
elevated
fungal
healthy controls
HLA-DR
ICU
ICU admission
IL-10
IL-1α
IL-1β
IL-6
IL-8
Immune phenotype
immune response
Infection
lipopolysaccharide
Listeria monocytogene
Listeria monocytogenes
LPS
Lymphocytes
marker
monocyte
Monocyte activation
not differ
Pathogenesis
PD-1
plasma
Prognosis
recent
respiratory distress
response
SARS-CoV-2
second hit
Secondary infection
secondary infections
severe acute respiratory distress syndrome
susceptibility
syndrome
T cells
therapy
TNF
upregulation
were assessed
were used
yeast
[DOI] 10.3389/fimmu.2021.640644 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.640644 PMC 바로가기 [Article Type] Immunology
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients
Research
[키워드] acute respiratory distress syndrome
alveolar
Angiopoietin-2
ARDS
AUROC
bead-based multiplex immunoassay
Biomarker
Biomarkers
can be used
characterized
classical
Cohort
COVID-19
Date
detect
E-selectin
endothelial
endothelial injury
enrolled
epithelial
evaluate
exhibited
expression
Ferrara
Gas exchange
ICAM-1
ICU
ICU patient
Inclusion
Injury
intensive care unit
intercellular
Intercellular adhesion molecule-1
mechanically ventilated
mechanically ventilated patient
Mortality
Non-COVID-19
non-survivor
Non-survivors
not differ
P-selectin
Pathways
Patient
plasma
plasma concentration
predictor
Primary outcome
Prospective Study
pulmonary endothelial
pulmonary injury
RAGE
receptor
Receptor for advanced glycation end-products
reflect
Respiratory mechanics
Result
secondary outcome
selectin
statistically
survivor
Survivors
university
variable
vascular cell adhesion
Vascular cell adhesion protein 1
VCAM-1
was performed
with COVID-19
[DOI] 10.1186/s13054-021-03499-4 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13054-021-03499-4 PMC 바로가기 [Article Type] Research
Effects of Methylprednisolone on Ventilator-Free Days in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome and COVID-19: A Retrospective Study
Article
[키워드] 95% CI
acute respiratory distress
acute respiratory distress syndrome
analyzed
ARDS
benefit
Blood
Care
Combination
competing
confounder
coronavirus disease
COVID-19
Culture
cultures
Day
determine
dose
Effect
Efficacy
evaluate
hazard
hospital
Hospital mortality
hyperglycemia
incidence
inclusion criteria
increases in
inflammatory markers
Invasive mechanical ventilation
measurement
mechanical ventilation
median
Methylprednisolone
methylprednisolone group
moderate
multivariable
not differ
Organ failure
Patient
patients
patients with ARDS
positive
Primary outcome
Prone position
receive
regression analysis
respiratory
SARS-COV-2 infection
severe COVID-19
severity
significantly shorter
single-center study
Support
syndrome
the disease
Tocilizumab
Trial
two group
two groups
ventilator
ventilator-free day
Ventilator-free days
VFD
[DOI] 10.3390/jcm10040760 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm10040760 PMC 바로가기 [Article Type] Article